The company also reported that revenues for the first nine months of 2009 increased 4 percent over the same period last year, to a record $83.1 million.
Cryolife is an implantable biological medical device and cardiovascular tissue processing company.
Read Crylife’s release on third-quarter revenues.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
